Gene Query: CRY1

Dataset Description Geneva Score
Paxillin regulates genomic networks in prostate cancer [LNCaP] 41.63
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 35.86
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 32.66
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 31.16
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 29.9
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 28.46
R430: A potent inbibitor of DNA and RNA viruses 26.19
Selective suppression of endothelial cytokine production by progesterone receptor 24.15
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 24.15
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 23.36
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 21.68
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 20.85
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 20.71
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 19.17
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 18.64
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 18.62
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 18.09
Regionally specified human pluripotent stem cell-derived astrocytes 18.06
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 17.26
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 17.26
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 17.13
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 16.51
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 16.09
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 16.09
Transcriptomic and gene ontology profiling of the human corneal cell types 15.21
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 14.75
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 14.72
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 14.33
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 14.2
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 13.69
Regulation of protein translation during mitosis 13.52
Noncoding regions are the main source of targetable tumor-specific antigens 13.33
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 13.29
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 13.14
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 13.09
Tracking of dCas9-methyltransferase footprints 12.69
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 12.6
Transcriptome of activated human and mouse MAIT cells 12.32
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 12.24
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 12.14
Transcriptome analysis in Neobractatin treated cells 11.83
Transcriptomic profiling of human peripheral blood-derived mast cells 11.74
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 11.74
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 11.42
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 11.4
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.28
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 11.12
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.09
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 10.79
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 10.63
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 10.56
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 10.19
Human HAP1 cells before and after nutrient deprivation 10.19
RNA-seq of MDA-MB-231 cells with TET1 knockout 10.18
SRSF2 mutations impair hematopoiesis and alter exon recognition 9.9
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 9.9
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 9.79
SUV420H2 knockdown in PANC-1 9.77
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 9.67
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.63
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.63
Dtx3L and Androgen Signaling in Prostate Cancer 9.54
Gene expression in PANC1 cells treated with Rakicidin 9.36
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 9.02
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 8.64
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 8.38
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.33
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.33
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 8.3
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 8.3
RNA-sequencing of human tendon after injury 8.27
CircRNAome diversity in human mature B-cells, T-cells and monocytes 8.25
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 8.18
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.17
Functional role of SLIT2 and ROBO1 in trophoblasts 8.16
NKX2.2 8.1
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 8.1
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.0
mRNA-sequencing of breast cancer subtypes and normal tissue 8.0
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 7.97
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.96
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.96
Solid phase chemistry to covalently and reversibly capture thiolated RNA 7.86
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.82
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 7.5
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 7.5
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 7.49
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 7.49
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 7.37
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 7.33
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 7.16
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.14
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 7.12
Total RNA-seq in ALL-SIL upon TLX1 knockdown 7.1
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 7.02
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 7.02
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 6.97
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 6.97
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 6.9
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.89
Paxillin regulates genomic networks in prostate cancer [PC3] 6.82
The role of CFTR in islet function 6.76
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.65
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.55
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 6.55
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 6.55
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 6.5
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 6.43
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.42
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 6.35
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.33
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.31
RNA-seq of RKO cells with cTAZ KO or putback 6.29
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 6.27
Transcriptional dependencies in diffuse intrinsic pontine glioma 6.25
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 6.23
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 6.21
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 6.21
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.19
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 6.14
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 6.14
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.12
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 6.08
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.06
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.06
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.01
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 5.93
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.85
N6-methyladenine DNA Modification in Glioblastoma 5.85
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.84
Comparing gene expression in iPSC derived RPE from control and AMD donors 5.83
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 5.78
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 5.78
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.77
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.69
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.69
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.69
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 5.65
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.61
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.61
Zone dependent distinctive gene expression profile of the normal human liver tissue 5.57
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 5.56
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.56
Total RNA sequencing of APC mutant and wt colonic organoids 5.5
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 5.49
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.47
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.45
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 5.4
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 5.38
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.37
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 5.35
Gene expression analysis of dengue-infected cells 5.33
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.28
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.28
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 5.22
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 5.21
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 5.14
Gene expression alterations of pancreatic intraepithlial neoplasia 5.06
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 5.03
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.0
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.0
IDH3a KO RNA-seq 5.0
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.92
Characterization of human ILC2 subsets 4.91
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.9
Gene expression changes after LOC550643 silencing 4.84
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 4.83
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 4.83
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.82
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.82
Primary human trophoblast from term placenta 4.81
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 4.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.8
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 4.77
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.76
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.7
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.69
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.69
Ebola virus (EBOV) infection of ARPE-19 cells 4.67
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.62
Role of COP1 on MAP kinase transcriptional output in melanoma 4.6
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 4.58
Differential expression of genes in AD169-infected MRC5. 4.56
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 4.55
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 4.55
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.54
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.54
Gene expression in GBM with Cav3.2 inhibition 4.53
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.52
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 4.49
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.46
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 4.46
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 4.45
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 4.45
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.43
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.42
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.42
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 4.41
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.37
Gene expression signatures of innate lymphoid cells from human blood 4.33
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 4.33
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.31
Effect of from Human Umbilical Vein Endothelial Cells 4.29
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.29
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 4.29
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.28
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.24
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 4.23
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 4.23
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.22
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.22
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 4.18
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 4.16
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 4.16
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.14
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.14
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.13
Differentially expressed genes post knock down of lincDUSP26 4.13
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.1
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 4.09
AMPK signaling for naïve pluripotency 4.09
AMPK signaling for naïve pluripotency [Hs] 4.09
RNA sequencing of GlyH-101-treated MCF-7 cell line 4.06
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 4.02
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 4.0
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 3.98
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 3.98
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 3.97
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 3.97
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.96
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 3.95
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 3.94
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.93
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.93
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.92
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 3.91
RNA-seq of cells with TET1 knockout 3.87
FOXP1 orchestration of ASD-relevant signaling pathways. 3.82
3’ Uridylation Expands miRNA Target Repertoire 3.81
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 3.71
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.71
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.69
Toxoplasma gondii infection of human retinal pigment epithelial cells 3.69
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.67
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.66
Functional astrocytes differentiated from hiPSCs 3.63
The MEF2B Regulatory Network - RNA-seq data 3.58
The MEF2B Regulatory Network 3.58
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 3.55
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 3.55
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.54
HNRNPL and its RNA Targets in Prostate Cancer 3.53
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.53
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.53
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 3.53
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.52
Zika virus directly infects human peripheral neurons and induces cell death 3.49
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.48
RNA-seq of cancer cell lines treated with T-025 3.46
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.46
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 3.44
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.43
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 3.41
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.38
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.38
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.37
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.37
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 3.36
Identification of long noncoding RNAs regulated by p53 3.35
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.35
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.35
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.34
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.34
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.32
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.32
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 3.32
Transcriptome-wide identification of CELF2 functional targets in T cells 3.32
U2AF1 mutations alter splice site recognition in hematological malignancies 3.32
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 3.31
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 3.31
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.28
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 3.27
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 3.27
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.26
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.23
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.22
RNA-seq analysis of control and Myc-induced U2OS cells 3.22
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.21
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.21
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.2
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.19
Androgen Receptor-regulated genes in prostate cancer cells 3.19
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.18
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.17
GATA3-mediated chromatin reprogramming in breast cancer cells 3.16
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 3.14
Intrahepatic MAIT cell gene expression revealed by RNA-seq 3.1
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.08
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.07
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.01
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.0
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.0
Hepatitis C virus functionally sequesters miR-122 2.98
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.98
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 2.98
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.97
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.94
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.92
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.9
Genome-wide chromatin analysis of Ewing sarcoma 2.88
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 2.88
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.82
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.82
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.82
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.78
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.77
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.76
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.76
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.75
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 2.74
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.71
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.71
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.68
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.68
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.62
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 2.6
RNA expression analysis upon JMJD1C depletion 2.6
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.6
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.6
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.6
Global transcriptome analysis of HAP1 cells 2.58
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.55
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.52
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.51
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.48
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.44
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.41
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.41
Activity-dependent transcriptional changes in human neurons 2.38
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.36
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 2.34
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 2.34
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.32
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.25
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.25
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 2.23
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.22
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.22
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.22
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.2
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.17
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.16
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.16
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.11
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.09
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.06
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.04
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.02
Stem and effector CD8 T-cells from human cancers 2.0
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.99
IRF1 regulates IFN dependent and independent gene expression 1.96
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 1.94
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.94
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.94
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 1.94
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.91
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.91
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.9
RNA-Seq in PWS iPSC-derived neurons 1.81
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.81
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.81
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.8
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.79
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.79
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.79
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.79
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.78
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.75
Identification of renal resident macrophages across species [C1] 1.73
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.7
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.66
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.61
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.61
Induced DNA demethylation, genome instability and transcription 1.61
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.58
Transcriptome analysis of SKI knock-out in HL60 cells 1.56
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.56
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.55
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.55
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.54
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.54
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.51
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 1.48
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.46
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.44
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.42
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.42
Human Treg IFNg/IL-10 subpopulations 1.4
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.37
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.37
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.35
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.33
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.32
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.31
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.28
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.28
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.28
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.26
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.26
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.26
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 1.24
Direct Isolation and Characterization of Human Nephron Progenitors. 1.22
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.21
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.21
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.19
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.19
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.19
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.17
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.16
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.16
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.13
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.13
Functional significance of the HIV-1 Tat signature amino acid residues 1.12
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.11
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.11
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.1
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.1
Single-cell analysis of adult human ovary using 10X genomics 1.1
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.1
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.08
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.08
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 1.07
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.0
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.0
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.97
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.96
Evaluating pre-clinical models for studying NASH driven HCC. 0.94
Gene expression activation in CLL mediated by MSCs contact 0.93
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.85
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.83
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.78
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.78
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.77
SF3B1 Degron knockdown RNA-seq 0.76
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.74
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.73
Transcriptomic analysis of LSD1 0.72
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.71
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.7
Dermal endothelial cells of type 2 diabetic patients 0.7
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.67
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.62
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.61
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.6
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.6
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.56
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  0.56
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.54
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.54
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.51
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.51
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.51
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.51
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.49
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.47
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.46
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.4
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.4
Identification of a LIF-responsive replication-competent human β cell 0.39
Modulation of nonsense-mediated decay by rapamycin 0.38
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.36
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.35
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.34
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.31
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.31
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.3
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.3
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.29
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.29
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.28
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.27
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.27
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.21
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.2
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.2
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.2
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.19
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.17
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.17
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.15
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.15
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.13
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.13
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.11
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.09
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.09
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.08
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.07
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation